Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Stomatin-like protein 3 (STOML3) is an integral membrane protein that belongs to the stomatin-domain family, characterized by a conserved core stomatin domain and a short hydrophobic hairpin responsible for membrane insertion[1][3][4]. STOML3 is predominantly expressed in sensory neurons—including olfactory sensory neurons and dorsal root ganglia—where it is essential for normal touch sensation and mechanosensory transduction[3][4]. It forms complexes with other stomatin-domain proteins and modulates the activity of key mechanosensitive ion channels such as ASICs (acid-sensing ion channels) and Piezo channels, thereby regulating neuronal sensitivity to mechanical and chemical stimuli[1][2][3]. STOML3 acts, at least in part, by binding membrane cholesterol, increasing membrane stiffness, and enabling efficient force transfer to mechanosensitive ion channels[2]. Its loss impairs sensory neuron function and mechanosensation, leading to decreased neuronal excitability and blunted perception of touch or pain, as shown in knockout models[2][4]. STOML3’s role in mechanotransduction and pain pathways makes it a candidate therapeutic target for managing chronic pain syndromes[2]. No specific drugs are yet marketed to target STOML3, but its mechanistic pathway is seen as a potential strategy for modulation of chronic pain[2].
Modulates membrane mechanics by binding cholesterol; Facilitates force transfer to, and tunes, mechanosensitive ion channels (notably Piezo1, Piezo2, ASICs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stomatin-like protein 3 (STOML3).